|
|
 |
Vice-President Prof. Dr. Paul L. Herrling
- Employed by Sandoz Pharma after obtaining his PhD in 1975; appointed director of the Sandoz Forschungsinstitut in Bern in 1985
- 1996, in charge of integrating the respective research organisations of Sandoz and Ciba-Geigy when the two companies merged to create Novartis
- 2001, appointed professor of biopharmacology and drug discovery science at Basel University; 2002, «Full adjunct Professor» at the Scripps Research Institute in La Jolla (USA)
- Head of «Corporate research» of Novartis since 2002
- Active in many scientific publications, member of the Novartis Foundation Board and director of Chiron, Emeryville (CA)
- Since 2004 Member of the ETH Board
- Since 1 January 2008 Vice-President of the ETH Board
|
 |
